The global market for Veterinary Anesthesia Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. White Paper on China"s Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 141%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Veterinary Anesthesia Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Anesthesia Drug.

The Veterinary Anesthesia Drug market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Veterinary Anesthesia Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Veterinary Anesthesia Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Veterinary Anesthesia Drug Market Report

Report Metric	Details
Report Name	Veterinary Anesthesia Drug Market
Accounted market size in 2021	$ 38.3 billion
Base Year	2021
Segment by Type	Ketamine Propofol Thiopental Others
Segment by Application	Pet Agricultural Livestock Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Dechra, LGC Group, AuroMedics, Evonik, Gedeon Richter, Midas Pharma, Fresenius Kabi AG, AstraZeneca
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Veterinary Anesthesia Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Veterinary Anesthesia Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

What is the Veterinary Anesthesia Drug Market share by application?

Ans: From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%.

Who are the main players in the Veterinary Anesthesia Drug Market report?

Ans: The main players in the Veterinary Anesthesia Drug Market are Dechra, LGC Group, AuroMedics, Evonik, Gedeon Richter, Midas Pharma, Fresenius Kabi AG, AstraZeneca

What are the Application segmentation covered in the Veterinary Anesthesia Drug Market report?

Ans: The Applications covered in the Veterinary Anesthesia Drug Market report are Pet, Agricultural Livestock, Others

What are the Type segmentation covered in the Veterinary Anesthesia Drug Market report?

Ans: The Types covered in the Veterinary Anesthesia Drug Market report are Ketamine, Propofol, Thiopental, Others

1 Veterinary Anesthesia Drug Market Overview

1.1 Product Definition

1.2 Veterinary Anesthesia Drug by Type

1.2.1 Global Veterinary Anesthesia Drug Market Value Comparison by Type (2024 VS 2031)

1.2.2 Ketamine

1.2.3 Propofol

1.2.4 Thiopental

1.2.5 Others

1.3 Veterinary Anesthesia Drug by Application

1.3.1 Global Veterinary Anesthesia Drug Market Value by Application (2024 VS 2031)

1.3.2 Pet

1.3.3 Agricultural Livestock

1.3.4 Others

1.4 Global Veterinary Anesthesia Drug Market Size Estimates and Forecasts

1.4.1 Global Veterinary Anesthesia Drug Revenue 2020-2031

1.4.2 Global Veterinary Anesthesia Drug Sales 2020-2031

1.4.3 Global Veterinary Anesthesia Drug Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Veterinary Anesthesia Drug Market Competition by Manufacturers

2.1 Global Veterinary Anesthesia Drug Sales Market Share by Manufacturers (2020-2025)

2.2 Global Veterinary Anesthesia Drug Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Veterinary Anesthesia Drug Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Veterinary Anesthesia Drug, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Veterinary Anesthesia Drug, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Veterinary Anesthesia Drug, Product Type & Application

2.7 Global Key Manufacturers of Veterinary Anesthesia Drug, Date of Enter into This Industry

2.8 Global Veterinary Anesthesia Drug Market Competitive Situation and Trends

2.8.1 Global Veterinary Anesthesia Drug Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Veterinary Anesthesia Drug Players Market Share by Revenue

2.8.3 Global Veterinary Anesthesia Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Veterinary Anesthesia Drug Market Scenario by Region

3.1 Global Veterinary Anesthesia Drug Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Veterinary Anesthesia Drug Sales by Region: 2020-2031

3.2.1 Global Veterinary Anesthesia Drug Sales by Region: 2020-2025

3.2.2 Global Veterinary Anesthesia Drug Sales by Region: 2026-2031

3.3 Global Veterinary Anesthesia Drug Revenue by Region: 2020-2031

3.3.1 Global Veterinary Anesthesia Drug Revenue by Region: 2020-2025

3.3.2 Global Veterinary Anesthesia Drug Revenue by Region: 2026-2031

3.4 North America Veterinary Anesthesia Drug Market Facts & Figures by Country

3.4.1 North America Veterinary Anesthesia Drug Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Veterinary Anesthesia Drug Sales by Country (2020-2031)

3.4.3 North America Veterinary Anesthesia Drug Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Veterinary Anesthesia Drug Market Facts & Figures by Country

3.5.1 Europe Veterinary Anesthesia Drug Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Veterinary Anesthesia Drug Sales by Country (2020-2031)

3.5.3 Europe Veterinary Anesthesia Drug Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Veterinary Anesthesia Drug Market Facts & Figures by Region

3.6.1 Asia Pacific Veterinary Anesthesia Drug Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Veterinary Anesthesia Drug Sales by Region (2020-2031)

3.6.3 Asia Pacific Veterinary Anesthesia Drug Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Veterinary Anesthesia Drug Market Facts & Figures by Country

3.7.1 Latin America Veterinary Anesthesia Drug Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Veterinary Anesthesia Drug Sales by Country (2020-2031)

3.7.3 Latin America Veterinary Anesthesia Drug Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Veterinary Anesthesia Drug Market Facts & Figures by Country

3.8.1 Middle East and Africa Veterinary Anesthesia Drug Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Veterinary Anesthesia Drug Sales by Country (2020-2031)

3.8.3 Middle East and Africa Veterinary Anesthesia Drug Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Veterinary Anesthesia Drug Sales by Type (2020-2031)

4.1.1 Global Veterinary Anesthesia Drug Sales by Type (2020-2025)

4.1.2 Global Veterinary Anesthesia Drug Sales by Type (2026-2031)

4.1.3 Global Veterinary Anesthesia Drug Sales Market Share by Type (2020-2031)

4.2 Global Veterinary Anesthesia Drug Revenue by Type (2020-2031)

4.2.1 Global Veterinary Anesthesia Drug Revenue by Type (2020-2025)

4.2.2 Global Veterinary Anesthesia Drug Revenue by Type (2026-2031)

4.2.3 Global Veterinary Anesthesia Drug Revenue Market Share by Type (2020-2031)

4.3 Global Veterinary Anesthesia Drug Price by Type (2020-2031)

5 Segment by Application

5.1 Global Veterinary Anesthesia Drug Sales by Application (2020-2031)

5.1.1 Global Veterinary Anesthesia Drug Sales by Application (2020-2025)

5.1.2 Global Veterinary Anesthesia Drug Sales by Application (2026-2031)

5.1.3 Global Veterinary Anesthesia Drug Sales Market Share by Application (2020-2031)

5.2 Global Veterinary Anesthesia Drug Revenue by Application (2020-2031)

5.2.1 Global Veterinary Anesthesia Drug Revenue by Application (2020-2025)

5.2.2 Global Veterinary Anesthesia Drug Revenue by Application (2026-2031)

5.2.3 Global Veterinary Anesthesia Drug Revenue Market Share by Application (2020-2031)

5.3 Global Veterinary Anesthesia Drug Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Dechra

6.1.1 Dechra Company Information

6.1.2 Dechra Description and Business Overview

6.1.3 Dechra Veterinary Anesthesia Drug Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Dechra Veterinary Anesthesia Drug Product Portfolio

6.1.5 Dechra Recent Developments/Updates

6.2 LGC Group

6.2.1 LGC Group Company Information

6.2.2 LGC Group Description and Business Overview

6.2.3 LGC Group Veterinary Anesthesia Drug Sales, Revenue and Gross Margin (2020-2025)

6.2.4 LGC Group Veterinary Anesthesia Drug Product Portfolio

6.2.5 LGC Group Recent Developments/Updates

6.3 AuroMedics

6.3.1 AuroMedics Company Information

6.3.2 AuroMedics Description and Business Overview

6.3.3 AuroMedics Veterinary Anesthesia Drug Sales, Revenue and Gross Margin (2020-2025)

6.3.4 AuroMedics Veterinary Anesthesia Drug Product Portfolio

6.3.5 AuroMedics Recent Developments/Updates

6.4 Evonik

6.4.1 Evonik Company Information

6.4.2 Evonik Description and Business Overview

6.4.3 Evonik Veterinary Anesthesia Drug Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Evonik Veterinary Anesthesia Drug Product Portfolio

6.4.5 Evonik Recent Developments/Updates

6.5 Gedeon Richter

6.5.1 Gedeon Richter Company Information

6.5.2 Gedeon Richter Description and Business Overview

6.5.3 Gedeon Richter Veterinary Anesthesia Drug Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Gedeon Richter Veterinary Anesthesia Drug Product Portfolio

6.5.5 Gedeon Richter Recent Developments/Updates

6.6 Midas Pharma

6.6.1 Midas Pharma Company Information

6.6.2 Midas Pharma Description and Business Overview

6.6.3 Midas Pharma Veterinary Anesthesia Drug Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Midas Pharma Veterinary Anesthesia Drug Product Portfolio

6.6.5 Midas Pharma Recent Developments/Updates

6.7 Fresenius Kabi AG

6.7.1 Fresenius Kabi AG Company Information

6.7.2 Fresenius Kabi AG Description and Business Overview

6.7.3 Fresenius Kabi AG Veterinary Anesthesia Drug Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Fresenius Kabi AG Veterinary Anesthesia Drug Product Portfolio

6.7.5 Fresenius Kabi AG Recent Developments/Updates

6.8 AstraZeneca

6.8.1 AstraZeneca Company Information

6.8.2 AstraZeneca Description and Business Overview

6.8.3 AstraZeneca Veterinary Anesthesia Drug Sales, Revenue and Gross Margin (2020-2025)

6.8.4 AstraZeneca Veterinary Anesthesia Drug Product Portfolio

6.8.5 AstraZeneca Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Veterinary Anesthesia Drug Industry Chain Analysis

7.2 Veterinary Anesthesia Drug Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Veterinary Anesthesia Drug Production Mode & Process Analysis

7.4 Veterinary Anesthesia Drug Sales and Marketing

7.4.1 Veterinary Anesthesia Drug Sales Channels

7.4.2 Veterinary Anesthesia Drug Distributors

7.5 Veterinary Anesthesia Drug Customer Analysis

8 Veterinary Anesthesia Drug Market Dynamics

8.1 Veterinary Anesthesia Drug Industry Trends

8.2 Veterinary Anesthesia Drug Market Drivers

8.3 Veterinary Anesthesia Drug Market Challenges

8.4 Veterinary Anesthesia Drug Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Global Veterinary Anesthesia Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Veterinary Anesthesia Drug Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Veterinary Anesthesia Drug Market Competitive Situation by Manufacturers in 2024

Table 4. Global Veterinary Anesthesia Drug Sales (Tons) of Key Manufacturers (2020-2025)

Table 5. Global Veterinary Anesthesia Drug Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Veterinary Anesthesia Drug Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Veterinary Anesthesia Drug Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Veterinary Anesthesia Drug Average Price (US$/Ton) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Veterinary Anesthesia Drug, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Veterinary Anesthesia Drug, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Veterinary Anesthesia Drug, Product Type & Application

Table 12. Global Key Manufacturers of Veterinary Anesthesia Drug, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Veterinary Anesthesia Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Anesthesia Drug as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Veterinary Anesthesia Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Veterinary Anesthesia Drug Sales by Region (2020-2025) & (Tons)

Table 18. Global Veterinary Anesthesia Drug Sales Market Share by Region (2020-2025)

Table 19. Global Veterinary Anesthesia Drug Sales by Region (2026-2031) & (Tons)

Table 20. Global Veterinary Anesthesia Drug Sales Market Share by Region (2026-2031)

Table 21. Global Veterinary Anesthesia Drug Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Veterinary Anesthesia Drug Revenue Market Share by Region (2020-2025)

Table 23. Global Veterinary Anesthesia Drug Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Veterinary Anesthesia Drug Revenue Market Share by Region (2026-2031)

Table 25. North America Veterinary Anesthesia Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Veterinary Anesthesia Drug Sales by Country (2020-2025) & (Tons)

Table 27. North America Veterinary Anesthesia Drug Sales by Country (2026-2031) & (Tons)

Table 28. North America Veterinary Anesthesia Drug Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Veterinary Anesthesia Drug Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Veterinary Anesthesia Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Veterinary Anesthesia Drug Sales by Country (2020-2025) & (Tons)

Table 32. Europe Veterinary Anesthesia Drug Sales by Country (2026-2031) & (Tons)

Table 33. Europe Veterinary Anesthesia Drug Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Veterinary Anesthesia Drug Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Veterinary Anesthesia Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Veterinary Anesthesia Drug Sales by Region (2020-2025) & (Tons)

Table 37. Asia Pacific Veterinary Anesthesia Drug Sales by Region (2026-2031) & (Tons)

Table 38. Asia Pacific Veterinary Anesthesia Drug Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Veterinary Anesthesia Drug Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Veterinary Anesthesia Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Veterinary Anesthesia Drug Sales by Country (2020-2025) & (Tons)

Table 42. Latin America Veterinary Anesthesia Drug Sales by Country (2026-2031) & (Tons)

Table 43. Latin America Veterinary Anesthesia Drug Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Veterinary Anesthesia Drug Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Veterinary Anesthesia Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Veterinary Anesthesia Drug Sales by Country (2020-2025) & (Tons)

Table 47. Middle East and Africa Veterinary Anesthesia Drug Sales by Country (2026-2031) & (Tons)

Table 48. Middle East and Africa Veterinary Anesthesia Drug Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Veterinary Anesthesia Drug Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Veterinary Anesthesia Drug Sales (Tons) by Type (2020-2025)

Table 51. Global Veterinary Anesthesia Drug Sales (Tons) by Type (2026-2031)

Table 52. Global Veterinary Anesthesia Drug Sales Market Share by Type (2020-2025)

Table 53. Global Veterinary Anesthesia Drug Sales Market Share by Type (2026-2031)

Table 54. Global Veterinary Anesthesia Drug Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Veterinary Anesthesia Drug Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Veterinary Anesthesia Drug Revenue Market Share by Type (2020-2025)

Table 57. Global Veterinary Anesthesia Drug Revenue Market Share by Type (2026-2031)

Table 58. Global Veterinary Anesthesia Drug Price (US$/Ton) by Type (2020-2025)

Table 59. Global Veterinary Anesthesia Drug Price (US$/Ton) by Type (2026-2031)

Table 60. Global Veterinary Anesthesia Drug Sales (Tons) by Application (2020-2025)

Table 61. Global Veterinary Anesthesia Drug Sales (Tons) by Application (2026-2031)

Table 62. Global Veterinary Anesthesia Drug Sales Market Share by Application (2020-2025)

Table 63. Global Veterinary Anesthesia Drug Sales Market Share by Application (2026-2031)

Table 64. Global Veterinary Anesthesia Drug Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Veterinary Anesthesia Drug Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Veterinary Anesthesia Drug Revenue Market Share by Application (2020-2025)

Table 67. Global Veterinary Anesthesia Drug Revenue Market Share by Application (2026-2031)

Table 68. Global Veterinary Anesthesia Drug Price (US$/Ton) by Application (2020-2025)

Table 69. Global Veterinary Anesthesia Drug Price (US$/Ton) by Application (2026-2031)

Table 70. Dechra Company Information

Table 71. Dechra Description and Business Overview

Table 72. Dechra Veterinary Anesthesia Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 73. Dechra Veterinary Anesthesia Drug Product

Table 74. Dechra Recent Developments/Updates

Table 75. LGC Group Company Information

Table 76. LGC Group Description and Business Overview

Table 77. LGC Group Veterinary Anesthesia Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 78. LGC Group Veterinary Anesthesia Drug Product

Table 79. LGC Group Recent Developments/Updates

Table 80. AuroMedics Company Information

Table 81. AuroMedics Description and Business Overview

Table 82. AuroMedics Veterinary Anesthesia Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 83. AuroMedics Veterinary Anesthesia Drug Product

Table 84. AuroMedics Recent Developments/Updates

Table 85. Evonik Company Information

Table 86. Evonik Description and Business Overview

Table 87. Evonik Veterinary Anesthesia Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 88. Evonik Veterinary Anesthesia Drug Product

Table 89. Evonik Recent Developments/Updates

Table 90. Gedeon Richter Company Information

Table 91. Gedeon Richter Description and Business Overview

Table 92. Gedeon Richter Veterinary Anesthesia Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 93. Gedeon Richter Veterinary Anesthesia Drug Product

Table 94. Gedeon Richter Recent Developments/Updates

Table 95. Midas Pharma Company Information

Table 96. Midas Pharma Description and Business Overview

Table 97. Midas Pharma Veterinary Anesthesia Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 98. Midas Pharma Veterinary Anesthesia Drug Product

Table 99. Midas Pharma Recent Developments/Updates

Table 100. Fresenius Kabi AG Company Information

Table 101. Fresenius Kabi AG Description and Business Overview

Table 102. Fresenius Kabi AG Veterinary Anesthesia Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 103. Fresenius Kabi AG Veterinary Anesthesia Drug Product

Table 104. Fresenius Kabi AG Recent Developments/Updates

Table 105. AstraZeneca Company Information

Table 106. AstraZeneca Description and Business Overview

Table 107. AstraZeneca Veterinary Anesthesia Drug Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 108. AstraZeneca Veterinary Anesthesia Drug Product

Table 109. AstraZeneca Recent Developments/Updates

Table 110. Key Raw Materials Lists

Table 111. Raw Materials Key Suppliers Lists

Table 112. Veterinary Anesthesia Drug Distributors List

Table 113. Veterinary Anesthesia Drug Customers List

Table 114. Veterinary Anesthesia Drug Market Trends

Table 115. Veterinary Anesthesia Drug Market Drivers

Table 116. Veterinary Anesthesia Drug Market Challenges

Table 117. Veterinary Anesthesia Drug Market Restraints

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

Table 121. Authors List of This Report

List of Figures

Figure 1. Product Picture of Veterinary Anesthesia Drug

Figure 2. Global Veterinary Anesthesia Drug Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Veterinary Anesthesia Drug Market Share by Type: 2024 & 2031

Figure 4. Ketamine Product Picture

Figure 5. Propofol Product Picture

Figure 6. Thiopental Product Picture

Figure 7. Others Product Picture

Figure 8. Global Veterinary Anesthesia Drug Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Veterinary Anesthesia Drug Market Share by Application: 2024 & 2031

Figure 10. Pet

Figure 11. Agricultural Livestock

Figure 12. Others

Figure 13. Global Veterinary Anesthesia Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Veterinary Anesthesia Drug Market Size (2020-2031) & (US$ Million)

Figure 15. Global Veterinary Anesthesia Drug Sales (2020-2031) & (Tons)

Figure 16. Global Veterinary Anesthesia Drug Average Price (US$/Ton) & (2020-2031)

Figure 17. Veterinary Anesthesia Drug Report Years Considered

Figure 18. Veterinary Anesthesia Drug Sales Share by Manufacturers in 2024

Figure 19. Global Veterinary Anesthesia Drug Revenue Share by Manufacturers in 2024

Figure 20. Global 5 and 10 Largest Veterinary Anesthesia Drug Players: Market Share by Revenue in Veterinary Anesthesia Drug in 2024

Figure 21. Veterinary Anesthesia Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 22. Global Veterinary Anesthesia Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 23. North America Veterinary Anesthesia Drug Sales Market Share by Country (2020-2031)

Figure 24. North America Veterinary Anesthesia Drug Revenue Market Share by Country (2020-2031)

Figure 25. U.S. Veterinary Anesthesia Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Canada Veterinary Anesthesia Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Europe Veterinary Anesthesia Drug Sales Market Share by Country (2020-2031)

Figure 28. Europe Veterinary Anesthesia Drug Revenue Market Share by Country (2020-2031)

Figure 29. Germany Veterinary Anesthesia Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. France Veterinary Anesthesia Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. U.K. Veterinary Anesthesia Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Italy Veterinary Anesthesia Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Russia Veterinary Anesthesia Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Asia Pacific Veterinary Anesthesia Drug Sales Market Share by Region (2020-2031)

Figure 35. Asia Pacific Veterinary Anesthesia Drug Revenue Market Share by Region (2020-2031)

Figure 36. China Veterinary Anesthesia Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Japan Veterinary Anesthesia Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. South Korea Veterinary Anesthesia Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. India Veterinary Anesthesia Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Australia Veterinary Anesthesia Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Taiwan Veterinary Anesthesia Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Indonesia Veterinary Anesthesia Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Thailand Veterinary Anesthesia Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Malaysia Veterinary Anesthesia Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Philippines Veterinary Anesthesia Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Latin America Veterinary Anesthesia Drug Sales Market Share by Country (2020-2031)

Figure 47. Latin America Veterinary Anesthesia Drug Revenue Market Share by Country (2020-2031)

Figure 48. Mexico Veterinary Anesthesia Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Brazil Veterinary Anesthesia Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Argentina Veterinary Anesthesia Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Middle East and Africa Veterinary Anesthesia Drug Sales Market Share by Country (2020-2031)

Figure 52. Middle East and Africa Veterinary Anesthesia Drug Revenue Market Share by Country (2020-2031)

Figure 53. Turkey Veterinary Anesthesia Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Saudi Arabia Veterinary Anesthesia Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. U.A.E Veterinary Anesthesia Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. Global Sales Market Share of Veterinary Anesthesia Drug by Type (2020-2031)

Figure 57. Global Revenue Market Share of Veterinary Anesthesia Drug by Type (2020-2031)

Figure 58. Global Veterinary Anesthesia Drug Price (US$/Ton) by Type (2020-2031)

Figure 59. Global Sales Market Share of Veterinary Anesthesia Drug by Application (2020-2031)

Figure 60. Global Revenue Market Share of Veterinary Anesthesia Drug by Application (2020-2031)

Figure 61. Global Veterinary Anesthesia Drug Price (US$/Ton) by Application (2020-2031)

Figure 62. Veterinary Anesthesia Drug Value Chain

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions